Healthcare & Biotech Developments
Regeneron Pharmaceuticals (REGN) won approval in Japan for its Dupixent® (dupilumab) as the first-ever biologic for chronic obstructive pulmonary disease—a breakthrough that opens new treatment avenues for COPD patients. Read the full approval details.
Lexicon Pharmaceuticals (LXRX) inked an exclusive worldwide license with Novo Nordisk for its first‐in‐class oral drug candidate LX9851 targeting obesity and metabolic disorders, with potential payments reaching $1 billion. Learn about the arrangement.
Bristol Myers Squibb (BMY) received a positive CHMP opinion for its new subcutaneous formulation of Opdivo® (nivolumab) for multiple solid tumor indications—a move that could streamline cancer care. More on the trial results.
Genelux Corporation (GNLX) reported its Q4 and full‐year 2024 financial results with key advancements in its oncology pipeline, including FDA alignment for Olvi‑Vec in platinum resistant ovarian cancer. Read the full update.
bluebird bio (BLUE) confirmed it received an unsolicited non‑binding acquisition proposal from Ayrmid at $4.50 per share in cash plus a contingent value right, challenging its existing merger agreement. Get the full story.
Alnylam Pharmaceuticals (Nasdaq: ALNY) announced FDA approval of Qfitlia™ (fitusiran), the first siRNA therapeutic for hemophilia A or B treatment. The therapy, approved for patients 12 years and older, demonstrated a 90% reduction in annualized bleeding rates via subcutaneous injections every two months. Under its collaboration with Sanofi, Alnylam is set to earn tiered royalties on global net sales. Discover more from the approval report.
HilleVax (HLVX) reported full‐year 2024 financial results, with cash at $171.4 million as of year-end. The company saw a contraction in R&D expenses alongside a widened net loss of $147.3 million, reflecting adjustments in clinical development spending. Review the detailed update.
Vertex Pharmaceuticals (VRTX) provided key updates to its Type 1 diabetes portfolio. While its encapsulated islet cell therapy VX‑264 missed efficacy endpoints, its fully differentiated islet cell therapy, zimislecel, is advancing in Phase 3 trials with the potential to benefit around 60,000 people. See the full update.
Corporate & Strategic Transactions and Earnings Updates
Woodside (WDS) is set to divest its Greater Angostura assets in Trinidad and Tobago for $206 million, a move aimed at bolstering near‐term cash flows and enabling future investments. Find out the transaction details.
Atlantic International Corp. (ATLN) posted robust 2024 results with full‐year revenue of $442.6 million (up 10.3%) and Q4 revenue of $129.5 million (up 11.5%), showcasing the success of its dual organic and M&A growth strategy. Read the report.
Dominari Holdings (DOMH) impressed with preliminary FY 2024 financials as revenue surged to approximately $19 million—a dramatic 900% jump from 2023—supported by a new Bitcoin treasury strategy and a co‐founded data centers venture. More insights are available here.
Pactiv Evergreen (PTVE) secured all necessary regulatory approvals for its acquisition by Novolex at $18.00 per share, initiating the company’s transition to private ownership. Read the full announcement.
FutureFuel Corp. (FF) released its 2024 financial results amid notable declines: net income fell to $15.5 million from $37.4 million, and annual revenues dropped 34% to $243.3 million, impacted by chemical customer destocking and reduced biodiesel yields leading to a temporary plant shutdown. See the detailed review.
Markforged (MKFG) announced mixed Q4 and full‐year 2024 results with Q4 revenue at $22.4 million and a reduced net loss of $11.9 million, even as it prepares for an all‑cash acquisition by Nano Dimension at $5.00 per share, expected to close by Q2 2025. Read the full report.
Mawson Infrastructure Group (MIGI) reported strong fiscal year 2024 financial results with overall revenue growth of 36% to $59.3 million and digital colocation revenue surging 136% year‑over‑year to $38.5 million. The company also expanded its operational capacity to 129 MW and is advancing into AI and HPC markets. Explore the detailed performance update.
Largo (TSX: LGO) (NASDAQ: LGO) reported Q4 and full‑year 2024 financial results, revealing Q4 revenues declining to $24.3 million amid challenging vanadium market conditions while implementing an operational turnaround plan and cost optimization initiatives. Learn more in the full results report.
Golden Ocean Group (GOGL) announced significant changes to its Board of Directors with the appointment of Carl Erik Steen and James Ayers, bolstering its leadership in the shipping and offshore energy sectors. Read the board update.
Innovative Industrial Properties (IIPR), a cannabis‐focused REIT, reported defaults affecting several tenants, including 4Front Ventures, Gold Flora, and TILT Holdings, and detailed plans for aggressive legal remedies amid challenging market conditions. See the full report.
GigaMedia (GIGM) released its Q4 and full‐year 2024 financial results, with annual revenues of $3.0 million (down 30.8% from 2023) yet a strong cash position of $35.1 million and plans to focus on AI‐based content creation tools. Discover the detailed update.
Technology, Mobility & Fintech Innovations
Ascent Solar Technologies (ASTI) set a record by delivering spaceflight‐ready photovoltaic blankets to a major European space systems provider within two weeks—a key milestone for its Plug & Fly™ program. Check out the coverage.
Pony.ai (PONY) secured the first permit for fully driverless robotaxi operations in Shenzhen’s city centers, marking a significant step forward in autonomous mobility. More details are available here.
Baidu's Apollo Go (BIDU) expanded its international ambitions by partnering with Dubai’s Roads and Transport Authority to deploy 100 fully autonomous RT6 robotaxis by the end of 2025 and establish Abu Dhabi’s largest driverless fleet. Read the strategy update.
Xos, Inc. (XOS) reported record‐breaking 2024 results with 25% revenue growth to $56.0 million and its first‐ever positive free cash flow of $3.3 million, driven by robust unit deliveries and a major order from UPS. See the full report.
Lightwave Logic (LWLG) announced the controlled availability of its silicon photonics Process Design Kit, designed to integrate electro‑optic polymers into silicon photonic integrated circuits for AI and networking applications—an enabling technology for next‑generation innovations. More on the technology announcement.
MultiSensor AI Holdings (NASDAQ: MSAI) reported strong Q4 and full‐year 2024 results, with full‐year revenue growing 36% to $7.4 million and significant improvements in operational metrics including a 360% increase in connected sensors. Discover the detailed performance update.
